Fast Five: iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program – Mass Device

Posted: Published on March 15th, 2024

This post was added by Dr Simmons

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Read the original:
Fast Five: iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program - Mass Device

Related Posts
This entry was posted in Medical Technology. Bookmark the permalink.

Comments are closed.